−700KRW
5.84 BKRW
177.34 BKRW
13.52 M
About SCD
Sector
CEO
In-Seok Jeon
Headquarters
Hwaseong-si
Website
Employees (FY)
394
Founded
1943
ISIN
KR7000250001
FIGI
BBG000CBJVQ4
SAM CHUN DANG PHARM Co., Ltd. engages in the manufacture of pharmaceuticals. Its products include antibiotics, cures for the circulatory and respiratory system, medicines for the digestive system and ophthalmology, and anti-inflammatory. The company was founded on December 29, 1943 and is headquartered in Hwaseong-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 000250 is 97100 KRW — it has decreased by 5.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SCD stocks are traded under the ticker 000250.
SCD revenue for the last quarter amounts to 44.30 B KRW despite the estimated figure of 48.25 B KRW. In the next quarter revenue is expected to reach 55.50 B KRW.
Yes, you can track SCD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 000250 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 394.00 employees. See our rating of the largest employees — is SCD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SCD EBITDA is 17.88 B KRW, and current EBITDA margin is 11.40%. See more stats in SCD financial statements.